Imunidade celular na Leishmaniose visceral
Carvalho Filho, Edgar Marcelino de.
Salvador; s.n; 1985. 133 p. tab.
Tese em Português | LILACS | ID: lil-151620
Documentos relacionados
VISCERAL LEISHMANIASIS FROM AN AREA PREVIOUSLY NOT KNOWN TO BE ENDEMIC; DANGUR, BENSHANGUL-GUMUZ, REGIONAL STATE, NORTHWEST ETHIOPIA: A CASE REPORT.
Source Tracing of Leishmania donovani in Emerging Foci of Visceral Leishmaniasis, Western Nepal.
Regulatory role of Transcription factor-EB (TFEB) in parasite control through alteration of antigen presentation in visceral leishmaniasis.
Rational repurposing, synthesis, <i>in vitro</i> and <i>in silico</i> studies of chromone-peptidyl hybrids as potential agents against <i>Leishmania donovani</i>.
IFN-γ<sup>+</sup> CD4<sup>+</sup>T cell-driven prophylactic potential of recombinant LDBPK_252400 hypothetical protein of Leishmania donovani against visceral leishmaniasis.
Does immune dysregulation contribute towards development of hypopigmentation in Indian post kala-azar dermal leishmaniasis?
Cytokine saga in visceral leishmaniasis.
The importance of T cell-derived cytokines in post-kala-azar dermal leishmaniasis.
Genetically modified live attenuated vaccine: A potential strategy to combat visceral leishmaniasis.
Interleukin 2 is an Upstream Regulator of CD4+ T Cells From Visceral Leishmaniasis Patients With Therapeutic Potential.